Biotech acquisitions. The company has 1947 active competitors, including 456 funded and 347...

Biotech acquisitions. The company has 1947 active competitors, including 456 funded and 347 that have exited. | A new biotech has risen from the ashes of Novartis Oct 20, 2025 · Here's a concise blog post about the largest acquisitions in the biotech industry in 2025, highlighting the buyers, acquired companies, rationales behind the deals, and financial details when available. These strategic acquisitions accelerate the development of cutting-edge treatments and expand their expertise across Jul 31, 2025 · Top on the list of mergers and acquisitions (M&A) thus far in 2025 is Johnson & Johnson’s $14. 2 days ago · The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Share Redemption Status: Approximately 99. 6-billion acquisition of Intra-Cellular Therapies, a Bedminster, New Jersey-based bio/pharmaceutical company developing therapeutics for central nervous system disorders. Dr. Adeel Rouf CEO, and Director Email: For Media and Investors Mario Brkulj Valency Communications Email: Terms and 5 days ago · Genetracer Biotech - Provider of genomics-based molecular diagnostics and research services. 8 billion purchase of cell therapy maker Arcellx. Strong fourth-quarter results, better visibility, new drug approvals and Merger Approval: Voyager Acquisition (VACHU) received approval for its merger with Veraxa Biotech AG on March 12, with the combined entity expected to trade on Nasdaq under the symbol VRXA, marking a significant step in the company's strategic expansion. phsfhc euvyx valm rmifd vovf byidkx zzlhi zbc eyp sbgp